SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022041
Filing Date
2019-11-08
Accepted
2019-11-08 07:31:25
Documents
51
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20190930_10q.htm 10-Q 724352
2 EXHIBIT 31.1 ex_162264.htm EX-31.1 17181
3 EXHIBIT 31.2 ex_162265.htm EX-31.2 15393
4 EXHIBIT 32.1 ex_162266.htm EX-32.1 10105
11 plxp20190930_10qimg001.jpg GRAPHIC 2960
12 plxp20190930_10qimg002.gif GRAPHIC 5059
13 plxp20190930_10qimg003.gif GRAPHIC 5851
14 plxp20190930_10qimg004.gif GRAPHIC 8076
  Complete submission text file 0001437749-19-022041.txt   3674763

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT plxp-20190930.xml EX-101.INS 600012
6 XBRL TAXONOMY EXTENSION SCHEMA plxp-20190930.xsd EX-101.SCH 34563
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20190930_cal.xml EX-101.CAL 35720
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20190930_def.xml EX-101.DEF 279560
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20190930_lab.xml EX-101.LAB 272997
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20190930_pre.xml EX-101.PRE 298324
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 191202084
SIC: 2834 Pharmaceutical Preparations